Literature DB >> 4208899

Effect of chemotherapeutic agents upon microorganisms isolated from cancer patients.

M C Goldschmidt, G P Bodey.   

Abstract

Attempting to explain the predominance of Pseudomonas in leukemic patients, five of the most common gram-negative organisms isolated from sites of infection in cancer patients were exposed to several of the chemotherapeutic agents used in the treatment of this disease (methotrexate, cytosine arabinoside, cyclophosphamide, and 6-mercaptopurine). At concentrations of 125 mug/ml or higher, methotrexate inhibited all organisms except Pseudomonas. Cytosine arabinoside inhibited Escherichia and Klebsiella but appeared to stimulate the growth of Pseudomonas slightly at the higher concentrations. Thus, significant differences existed in individual susceptibilities to these agents. Clinical isolates were more resistant than the corresponding laboratory strains not previously exposed to these compounds. The resistance of Escherichia coli to cyclophosphamide was decreased 26% when it was grown in mixed culture with Pseudomonas. Only Pseudomonas was resistant to all of these compounds whether in pure or mixed culture. These observations may help to explain, in part, the predominant role that Pseudomonas plays as an infectious agent in leukemic patients.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4208899      PMCID: PMC444220          DOI: 10.1128/AAC.1.4.348

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  SOME METABOLIC PROPERTIES OF NUCLEOTIDES OF 1-BETA-D-ARABINO-FURANOSYLCYTOSINE.

Authors:  P T CARDEILHAC; S S COHEN
Journal:  Cancer Res       Date:  1964-10       Impact factor: 12.701

2.  BACTEREMIA DUE TO GRAM-NEGATIVE RODS. A CLINICAL, BACTERIOLOGIC, SEROLOGIC AND IMMUNOFLUORESCENT STUDY.

Authors:  J I MAIZTEGUI; J Z BIEGELEISEN; W B CHERRY; E H KASS
Journal:  N Engl J Med       Date:  1965-02-04       Impact factor: 91.245

3.  Biochemistry of cancer.

Authors:  E P ANDERSON; L W LAW
Journal:  Annu Rev Biochem       Date:  1960       Impact factor: 23.643

4.  Screening for and biological characterization of antitumor agents using microorganisms.

Authors:  F M SCHABEL; R F PITTILLO
Journal:  Adv Appl Microbiol       Date:  1961       Impact factor: 5.086

5.  Infections in recipients of liver homografts.

Authors:  V A Fulginiti; R Scribner; C G Groth; C W Putnam; L Brettschneider; S Gilbert; K A Porter; T E Starzl
Journal:  N Engl J Med       Date:  1968-09-19       Impact factor: 91.245

6.  The nature and control of infections in patients with acute leukemia.

Authors:  E Frei; R H Levin; G P Bodey; E E Morse; E J Freireich
Journal:  Cancer Res       Date:  1965-10       Impact factor: 12.701

7.  Protected environment for cancer patients. Effect of a prophylactic antibiotic regimen on the microbial flora of patients undergoing cancer chemotherapy.

Authors:  G P Bodey; J Loftis; E Bowen
Journal:  Arch Intern Med       Date:  1968-07

Review 8.  Metabolic basis for the actions of analogs of purines and pyrimidines.

Authors:  G B Elion; G H Hitchings
Journal:  Adv Chemother       Date:  1965

Review 9.  Cancer chemotherapy with purine and pyrimidine analogues.

Authors:  C Heidelberger
Journal:  Annu Rev Pharmacol       Date:  1967       Impact factor: 13.820

10.  Epidemiological studies of Pseudomonas species in patients with leukemia.

Authors:  G P Bodey
Journal:  Am J Med Sci       Date:  1970-08       Impact factor: 2.378

View more
  8 in total

1.  Antibacterial activities of antineoplastic agents.

Authors:  C A Bodet; J H Jorgensen; D J Drutz
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

2.  Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans.

Authors:  G Samonis; N C Karyotakis; E J Anaissie; E Barbounakis; S Maraki; Y Tselentis; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Routine use of BACTEC 16B bottles to remove antibacterial and antitumor agents from blood cultures of cancer patients.

Authors:  R L Hopfer; D G Moore; V Fainstein; S Watkins; M Wenglar
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

4.  Prophylactic non-absorbable antibiotics in leukaemic patients.

Authors:  K King
Journal:  J Hyg (Lond)       Date:  1980-08

5.  Effects of cancer chemotherapy on the human aerobic oropharyngeal flora.

Authors:  K W Renard; M Marling-Cason; R G Sheehan; P A Mackowiak
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

6.  Effect of two cancer chemotherapeutic agents on the antibacterial activity of three antimicrobial agents.

Authors:  M R Moody; M J Morris; V M Young; L A Moyé; S C Schimpff; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

7.  Bioassay of antibiotics in body fluids from patients receiving cancer chemotherapeutic agents.

Authors:  D N Wright; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

8.  Introduction of Pseudomonas aeruginosa into a hospital via vegetables.

Authors:  S D Kominos; C E Copeland; B Grosiak; B Postic
Journal:  Appl Microbiol       Date:  1972-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.